Owen Smith, General Manager of Bristol Myers Squibb New Zealand, said, "There was a clear and strong consensus from those consulted that reform is necessary to improve access to medicines in New Zealand to support better outcomes for patients and, over time, help reduce pressure across the wider health system.”
New report says faster and fairer access to medicines within reach for New Zealand
March 3, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
TGA approves GSK's six‑monthly treatment for severe eosinophilic asthma and nasal polyps
July 28, 2026 - - Latest News -
Long-COVID still reshaping life for medically vulnerable Australians
July 28, 2026 - - Latest News -
Australians with rare diseases still waiting too long for access to treatments
July 28, 2026 - - Latest News -
New research shows chronic pain is widespread and undertreated in Australia
July 28, 2026 - - Latest News -
Bellberry announces new appointment to board of directors
July 27, 2026 - - Latest News -
The power of this commitment might be as a comparison of national intent
July 27, 2026 - - Latest News -
New AI platform aims to give patients a strong voice in medicines funding
July 27, 2026 - - Latest News

